Characterization of chromatin extensively substituted with 5-bromodeoxyuridine.
D001665:Binding Sites; D001973:Bromodeoxyuridine / Q000494:pharmacology; D002250:Carbon Radioisotopes; D002499:Centrifugation, Density Gradient; D002843:Chromatin / Q000187:drug effects / Q000378:metabolism; D002942:Circular Dichroism; D004273:DNA, Neoplasm; D004355:Drug Stability; D004591:Electrophoresis, Polyacrylamide Gel; D005467:Floxuridine / Q000494:pharmacology; D006367:HeLa Cells / Q000166:cytology / Q000378:metabolism; D006657:Histones; D006358:Hot Temperature; D006801:Humans; D007553:Isotope Labeling; D008239:Lysine; D009363:Neoplasm Proteins; D009690:Nucleic Acid Conformation; D009691:Nucleic Acid Denaturation; D009698:Nucleoproteins; D011485:Protein Binding; D011487:Protein Conformation; D012334:RNA, Neoplasm; D013056:Spectrophotometry, Ultraviolet; D013997:Time Factors; D014316:Tritium
D002250:Carbon Radioisotopes; D002843:Chromatin; D004273:DNA, Neoplasm; D006657:Histones; D009363:Neoplasm Proteins; D009698:Nucleoproteins; D012334:RNA, Neoplasm; D005467:Floxuridine; D014316:Tritium; D001973:Bromodeoxyuridine; D008239:Lysine